EDUCATION

Medical School

  • American University of Beirut , 1995 , Beirut , Lebanon

Internship

  • American University of Beirut , 1996 , Beirut , Lebanon

Residency

  • American University of Beirut , 1998 , Beirut , Lebanon

Fellowship

  • Boston Children's Hospital , 2002 , Boston , MA

Residency

  • Boston Children's Hospital , 2004 , Boston , MA

CERTIFICATIONS

  • American Board of Allergy and Immunology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Yee CSK, Albuhairi S, Noh E, El-Khoury K, Rezaei S, Abdel-Gadir A, Umetsu DT, Burke-Roberts E, LeBovidge J, Schneider L, Rachid R. Long-term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab. J Allergy Clin Immunol Pract. 2018 Sep 26. View abstract
  2. Borzutzky A, Rauter I, Fried A, Rachid R, McDonald DR, Hammarstrom L, Grimbacher B, Abraham RS, Geha RS. Defective TLR9-driven STAT3 activation in B cells of patients with CVID. Clin Immunol. 2018 Aug 23; 197:40-44. View abstract
  3. Albuhairi S, Khoury KE, Yee C, Schneider L, Rachid R. A Twenty-two-year Experience with Hymenoptera Venom Immunotherapy in a US Pediatric Tertiary Care Center: 1996-2018. Ann Allergy Asthma Immunol. 2018 Aug 10. View abstract
  4. Abdel-Gadir A, Schneider L, Casini A, Charbonnier LM, Little SV, Harrington T, Umetsu DT, Rachid R, Chatila TA. Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function. Clin Exp Allergy. 2018 Jul; 48(7):825-836. View abstract
  5. Rachid R, Keet CA. Food Allergy: What's on the Menu in 2018? J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):419-420. View abstract
  6. Albuhairi S, Sare T, Lakin P, El Khoury K, Crestani E, Schneider LC, Anzaldi R, Patterson A, Rachid R. Systemic Reactions in Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy with and without Seasonal Dose Adjustment. J Allergy Clin Immunol Pract. 2018 Sep - Oct; 6(5):1711-1716.e4. View abstract
  7. Rachid R, Keet CA. Current Status and Unanswered Questions for Food Allergy Treatments. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):377-382. View abstract
  8. Bird JA, Spergel JM, Jones SM, Rachid R, Assa'ad AH, Wang J, Leonard SA, Laubach SS, Kim EH, Vickery BP, Davis BP, Heimall J, Cianferoni A, MacGinnitie AJ, Crestani E, Burks AW. Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):476-485.e3. View abstract
  9. Ballow M, Conaway MR, Sriaroon P, Rachid RA, Seeborg FO, Duff CM, Bonilla FA, Younger MEM, Shapiro R, Burns TM. Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16). J Allergy Clin Immunol. 2017 Jun; 139(6):2007-2010.e8. View abstract
  10. Rachid R, Chatila TA. The role of the gut microbiota in food allergy. Curr Opin Pediatr. 2016 12; 28(6):748-753. View abstract
  11. MacGinnitie AJ, Rachid R, Gragg H, Little SV, Lakin P, Cianferoni A, Heimall J, Makhija M, Robison R, Chinthrajah RS, Lee J, Lebovidge J, Dominguez T, Rooney C, Lewis MO, Koss J, Burke-Roberts E, Chin K, Logvinenko T, Pongracic JA, Umetsu DT, Spergel J, Nadeau KC, Schneider LC. Omalizumab facilitates rapid oral desensitization for peanut allergy. J Allergy Clin Immunol. 2017 Mar; 139(3):873-881.e8. View abstract
  12. Yee CS, Rachid R. The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions. Curr Allergy Asthma Rep. 2016 Apr; 16(4):25. View abstract
  13. Umetsu DT, Rachid R, Schneider LC. Oral immunotherapy and anti-IgE antibody treatment for food allergy. World Allergy Organ J. 2015; 8(1):20. View abstract
  14. Romberg N, Virdee M, Chamberlain N, Oe T, Schickel JN, Perkins T, Cantaert T, Rachid R, Rosengren S, Palazzo R, Geha R, Cunningham-Rundles C, Meffre E. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development. J Allergy Clin Immunol. 2015 Nov; 136(5):1315-25. View abstract
  15. Noval Rivas M, Burton OT, Wise P, Charbonnier LM, Georgiev P, Oettgen HC, Rachid R, Chatila TA. Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy. Immunity. 2015 Mar 17; 42(3):512-23. View abstract
  16. Burton OT, Logsdon SL, Zhou JS, Medina-Tamayo J, Abdel-Gadir A, Noval Rivas M, Koleoglou KJ, Chatila TA, Schneider LC, Rachid R, Umetsu DT, Oettgen HC. Oral immunotherapy induces IgG antibodies that act through Fc?RIIb to suppress IgE-mediated hypersensitivity. J Allergy Clin Immunol. 2014 Dec; 134(6):1310-1317.e6. View abstract
  17. Schneider LC, Rachid R, LeBovidge J, Blood E, Mittal M, Umetsu DT. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. J Allergy Clin Immunol. 2013 Dec; 132(6):1368-74. View abstract
  18. Romberg N, Chamberlain N, Saadoun D, Gentile M, Kinnunen T, Ng YS, Virdee M, Menard L, Cantaert T, Morbach H, Rachid R, Martinez-Pomar N, Matamoros N, Geha R, Grimbacher B, Cerutti A, Cunningham-Rundles C, Meffre E. CVID-associated TACI mutations affect autoreactive B cell selection and activation. J Clin Invest. 2013 Oct; 123(10):4283-93. View abstract
  19. Benhmidoune L, McHachi A, Boukhrissa M, Chakib A, Rachid R, Elbelhadji M, Amraoui A. [Use of bevacizumab in the treatment of complicated proliferative diabetic retinopathy]. J Fr Ophtalmol. 2013 Nov; 36(9):758-63. View abstract
  20. Lieberman P, Rachid R. Administration of intravenous immunoglobulin to a patient with hypogammaglobulinemia and anti-IgA antibodies. J Allergy Clin Immunol Pract. 2013 Nov-Dec; 1(6):704. View abstract
  21. Rachid R, Umetsu DT. Immunological mechanisms for desensitization and tolerance in food allergy. Semin Immunopathol. 2012 Sep; 34(5):689-702. View abstract
  22. Rachid R, Bonilla FA. Reply. J Allergy Clin Immunol. 2012 Aug; 130(2):554. View abstract
  23. Khoriaty E, McClain CD, Permaul P, Smith ER, Rachid R. Intraoperative anaphylaxis induced by the gelatin component of thrombin-soaked gelfoam in a pediatric patient. Ann Allergy Asthma Immunol. 2012 Mar; 108(3):209-10. View abstract
  24. Rachid R, Bonilla FA. The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature. J Allergy Clin Immunol. 2012 Mar; 129(3):628-34. View abstract
  25. Rachid R, Leslie D, Schneider L, Twarog F. Reply. J Allergy Clin Immunol. 2011 Oct; 128(4):905. View abstract
  26. Rachid R, Leslie D, Schneider L, Twarog F. Reply. J Allergy Clin Immunol. 2011 Jul; 128(1):251-2. View abstract
  27. Rachid R, Castells M, Cunningham-Rundles C, Bonilla FA. Association of anti-IgA antibodies with adverse reactions to ?-globulin infusion. J Allergy Clin Immunol. 2011 Jul; 128(1):228-230.e1. View abstract
  28. Rachid R, Leslie D, Schneider L, Twarog F. Hypersensitivity to systemic corticosteroids: an infrequent but potentially life-threatening condition. J Allergy Clin Immunol. 2011 Feb; 127(2):524-8. View abstract
  29. Castigli E, Wilson S, Garibyan L, Rachid R, Bonilla F, Schneider L, Morra M, Curran J, Geha R. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet. 2007 Apr; 39(4):430-1. View abstract
  30. Rachid R, Castigli E, Geha RS, Bonilla FA. TACI mutation in common variable immunodeficiency and IgA deficiency. Curr Allergy Asthma Rep. 2006 Sep; 6(5):357-62. View abstract
  31. Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet. 2005 Aug; 37(8):829-34. View abstract
  32. Sasahara Y*, Rachid R*, Byrne MJ, de la Fuente MA, Abraham RT, Ramesh N, Geha RS. * The first 2 authors contributed equally to the article. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol Cell. 2002; 10(6):1269-81. View abstract
  33. Muwakkit S, Rachid R, Bazarbachi A, Araysi T, Dbaibo GS. Treatment-resistant infantile Evans syndrome. Pediatr Int. 2001 Oct; 43(5):502-4. View abstract
  34. Mikati MA, Werner S, Gatt A, Liu Z, Rahmeh AA, Rachid RA, Stafstrom CE, Holmes GL. Consequences of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor blockade during status epilepticus in the developing brain. Brain Res Dev Brain Res. 1999 Mar 12; 113(1-2):139-42. View abstract
  35. Dbaibo GS, Pushkareva MY, Rachid RA, Alter N, Smyth MJ, Obeid LM, Hannun YA. p53-dependent ceramide response to genotoxic stress. J Clin Invest. 1998 Jul 15; 102(2):329-39. View abstract